MKM declines, for the 16th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Method
Every instrument specification quoted in an advertisement is a best case obtained on a calibration mixture, not on a submitted vial.
This article was revised after publication to separate the count of suppliers reporting an identity test on customer-facing certificates from the count supplying a laboratory report to the Journal on request. The two figures differ and the original table conflated them.
Two specifications are quoted for mass spectrometers and they are routinely conflated. Resolving power describes the instrument’s ability to present two ions of similar mass as two peaks rather than one, and is expressed as a mass divided by the peak width at half height. Mass accuracy describes how close a measured mass is to the true one, and is expressed in parts per million. An instrument with high resolving power and poor calibration will show you two peaks and put both in the wrong place. An instrument with excellent calibration and low resolving power will confidently report the average of two species as though it were one.
Because carbon-13 is present at roughly 1.1% natural abundance, a peptide containing one hundred and ninety carbon atoms will exist substantially as molecules containing one, two or three carbon-13 atoms. In a spectrum this appears as a series of peaks above the monoisotopic peak, separated in mass by approximately 1.00336 daltons and distributed in intensity according to the binomial statistics of the composition.
Two things follow, and both are practically useful. First, the spacing between adjacent isotope peaks in a charge-state cluster is one over the charge: a spacing of 0.5 on the m/z axis means the ion is doubly charged, 0.333 means triply, 0.25 means quadruply. This is the simplest charge assignment available and it requires no assumptions about the sample at all. Second, the relative intensities of the isotope peaks are predictable from the elemental composition, so a cluster whose shape departs markedly from the calculated envelope is evidence that two species are overlapping.
Both observations require an instrument capable of resolving the isotope peaks at the relevant m/z, which is where resolving power stops being a specification-sheet number and becomes the thing that determines whether a spectrum can be interpreted at all. Below roughly ten thousand resolving power, a multiply charged peptide envelope collapses into a single broad hump that carries neither the spacing nor the shape information.
Resolving power is conventionally defined as m divided by Δm, where Δm is the width of the peak at half its maximum height. An instrument quoted at 30,000 resolving power at m/z 1000 produces peaks roughly 0.033 wide at that position, which is sufficient to separate the isotope peaks of a triply charged ion. The same instrument at m/z 4000 may deliver rather less, because resolving power is not constant across the mass range and the figure on a specification sheet is quoted at whichever mass flatters it.
The number that matters for identity work is whether the instrument can separate two species whose masses differ by the amount you care about. To distinguish a deamidated peptide from its parent at four thousand daltons requires separating peaks 0.98 apart, which is a resolving power of roughly four thousand — modest. To distinguish a glutamine-for-lysine substitution requires separating peaks 0.036 apart at the same mass, which is a resolving power above one hundred thousand. Those two requirements differ by a factor of twenty-five and both are described in the trade by the same phrase, high resolution.
The Journal’s practice, adopted after an exchange with a laboratory that pointed out we had been sloppy about it, is to state the discrimination rather than the specification: not “high-resolution MS”, but “sufficient to resolve a 0.98-dalton shift at the parent mass”. It is longer and it says something.1
A matching mass has established that the vial contains something of the same elemental composition. That is not identity, and it is not close.
The standing rule in this departmentMass accuracy is the difference between the measured mass and the true mass, expressed in parts per million of the measured value. It depends on calibration, on the stability of the instrument’s electronics and temperature, on the number of ions arriving at the detector, and on whether an internal calibrant was co-analysed with the sample. It is not a fixed property of an instrument; it is a property of a measurement made on an instrument on a particular day.
Certificates in this market seldom state a tolerance at all. Where they do, the figure is usually expressed in daltons rather than parts per million and is generous: ±0.5 or ±1.0 dalton is common, which at incretin molecular weights corresponds to 120 to 240 parts per million and is achievable on almost any instrument sold in the last thirty years. A tolerance that no plausible measurement could fail is not an acceptance criterion. It is a formality.
What a meaningful criterion looks like is not mysterious. State the theoretical mass and its convention, state the observed mass, state the deviation in parts per million, and state the limit above which the result would have been reported as non-conforming. Four numbers, all of them already known to the analyst. The compendial framework for validating an analytical procedure asks for exactly this kind of specificity about what a test can discriminate, and the framework predates this market by decades.2
| Element of the identity claim | Certificates stating it (of 20) |
|---|---|
| A mass spectrometric identity test was performed | 14 |
| Both observed and theoretical mass given | 8 |
| Instrument or analyser class named | 6 |
| Ionisation source or mode named | 5 |
| A spectrum reproduced in the document | 5 |
| Charge state of the reported ion stated | 4 |
| Monoisotopic or average convention stated | 3 |
| An acceptance tolerance stated | 3 |
| Peptide mapping or MS/MS performed | 1 |
| Counts are of the most recent certificate supplied to the Journal by each of the twenty companies in the dossier programme as at the last quarterly cycle. A company is credited where the element appears anywhere on the document or on an attached laboratory report. No inference about material quality should be drawn from a documentary count. | |
A single quadrupole mass filter provides unit resolution and mass accuracy of a few tenths of a dalton. It is entirely adequate to confirm that a sample is broadly the compound expected and to detect large modifications, and it is the analyser in most low-cost LC-MS systems. It cannot resolve an isotopic envelope at peptide molecular weights and therefore cannot assign charge from spacing.
Time-of-flight analysers separate ions by the time they take to traverse a flight tube. A linear tube gives modest resolving power; adding a reflectron and delayed extraction raises it into the tens of thousands, and modern quadrupole time-of-flight hybrids achieve low single-figure parts-per-million accuracy with routine calibration. Orbital trapping instruments measure the frequency of ion oscillation in an electrostatic field and convert it by Fourier transform, delivering resolving powers from sixty thousand to several hundred thousand and sub-part-per-million accuracy with internal calibration. Fourier-transform ion cyclotron resonance remains the highest-performing class and the least common outside academic facilities.
What this hierarchy means for a reader of certificates is that the instrument named on the document sets a ceiling on what the document can claim, independent of the laboratory’s competence. An unnamed instrument leaves that ceiling unknown, which is why the Journal now treats the absence of an instrument name as a material omission rather than a stylistic one.
Every mass spectrometer is calibrated against a mixture of compounds of known exact mass, and every mass spectrometer drifts away from that calibration afterwards. The rate depends on the analyser type, on ambient temperature stability, and in trapping instruments on the number of ions in the trap: space-charge effects shift apparent masses in a manner that depends on how much sample was injected.
External calibration means the calibrant was run separately, before or after the samples. It is simple, it is what most routine work uses, and it is vulnerable to everything that happens between the calibration and the sample. Internal calibration means a compound of known mass was present in the same spectrum as the analyte, so the correction is applied to the measurement rather than to the instrument. Internal calibration is the reason sub-part-per-million figures are achievable at all, and it is the difference between a stated accuracy and a demonstrated one.
None of this is exotic or contested; it is ordinary laboratory practice, described in accreditation requirements as part of metrological traceability and in the pharmacopoeial chapters as part of system suitability.3 The reason it belongs in an article aimed at buyers is that it explains why two competent laboratories analysing the same vial on the same class of instrument can differ by tens of parts per million, and why the honest response to such a difference is to ask about calibration rather than about honesty.
This publication applies one rule to every identity claim it reports, and it is worth stating in isolation because it governs the rest. A mass measurement supports a statement about composition. Only a fragmentation or mapping experiment supports a statement about sequence. Where a source says identity was confirmed, we report that a mass was measured, unless we have seen evidence of the second kind.
The rule has consequences we accept. It makes our coverage read as more sceptical than the underlying documents, because the documents claim more than they establish. It occasionally irritates laboratories which have in fact done sequence-level work and have simply not printed it, and the remedy there is a two-line email which we are glad to receive. And it means we cannot describe any research-grade vial in this market as sequence-confirmed, because on the evidence available to us almost none are.
What the rule is not is an accusation. Nothing in this article suggests that vendors are selling material other than what they label, and the Journal has no evidence of that in respect of any company it covers. The claim is narrower and, we think, harder to argue with: the documentation in general circulation does not have the discriminating power that the language on it implies, and the gap between the two is where every avoidable dispute in this market begins.
m/z — mass-to-charge ratio, the quantity a mass spectrometer actually measures. Monoisotopic mass — mass calculated using the lightest stable isotope of each element. Average mass — mass calculated using standard atomic weights. Nominal mass — the integer sum of integer isotope masses; adequate for small molecules, useless here.
Resolving power — m divided by peak width at half height; the ability to separate nearby masses. Mass accuracy — deviation of a measurement from the true value, in parts per million. Mass defect — the difference between an exact mass and its nominal value, and the property that makes near-isobars separable.
Adduct — an ion formed by association with something other than a proton, commonly sodium or potassium. Charge-state envelope — the family of differently charged ions from one compound. Isobaric — of identical mass at the achieved precision. Isomeric — of identical composition and different structure. b and y ions — the complementary fragment series produced by amide-bond cleavage.
Precision in these terms is not decoration. Several disputes this department has been asked to adjudicate turned out, on inspection, to be disagreements about whether the word mass meant monoisotopic or average.
What remains genuinely open is stereochemistry. Racemisation during synthesis is a well-described chemical risk, it is invisible to every routine test sold to private buyers in this market, and the Journal has no basis for estimating how common it is. We would rather say that plainly than fill the gap with an inference. If any of the four independent services begins offering chiral amino-acid analysis at a price a private buyer would pay, this department will report the results.
Selected from correspondence received on this article. Writers are identified by initial, surname and city, verified before printing. Replies are from the desk that filed the piece or from the standards editor. Write to letters@compoundjournal.com.
You give the glutamine-to-lysine difference as 0.036 daltons and say it needs an orbital trap. In practice you also need the two species to be chromatographically separated or present in a sensible ratio, because at one per cent of the parent intensity the minor peak sits on the shoulder of the isotope envelope regardless of resolving power.
— D. Ferreira-Lopes, Porto
Yes, and this is the more useful statement of the problem. Resolving power is necessary and not sufficient; dynamic range and separation matter as much. We have added a sentence to the table note.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Three compendial method families are in routine use and a fourth, based on a recombinant enzyme rather than crab lysate, is now compendial in its own right.
The result is unremarkable. What the report omits is not.
Lot-level verification with a public report is a real and achievable thing. It exists in this market, on a minority of listings.
The result is unremarkable. What the report omits is not.
The supplier has not disputed the finding. It has not explained the gap either.